Page last updated: 2024-11-07

quebrachitol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

quebrachitol: RN given refers to (D-chiro)-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID151108
CHEMBL ID501109
CHEBI ID170050
CHEBI ID111
SCHEMBL ID240345
SCHEMBL ID22975188
MeSH IDM0158386

Synonyms (45)

Synonym
(1r,2s,4s,5r)-6-methoxycyclohexane-1,2,3,4,5-pentol
CHEBI:170050
l-chiro-inositol, 2-o-methyl-
quebrachit
quebrachitol, (-)-
quebrachitol
l-quebrachitol
nsc-26254
(-)-quebrachitol
642-38-6
C08257
1l-2-o-methyl-chiro-inositol
2B678708-4698-466E-88D8-3443A058E849
quebrachitol, l-
chebi:111 ,
CHEMBL501109
3564-07-6
d-chiro-inositol, 2-o-methyl-
2-o-methyl-chiro-inositol
S3223
M02437
FT-0625606
SCHEMBL240345
9w4jlq7i4w ,
brahol
2-o-methyl-l-chiro-inositol
l-(-)-2-o-methylinositol
inositol, 2-o-methyl-
inositol, 2-o-methyl-, l-chiro-
unii-9w4jlq7i4w
W-203384
pinitol tms
DSCFFEYYQKSRSV-FIZWYUIZSA-N
mfcd00021405
AKOS027327479
(1r,2s,3s,4s,5r,6r)-6-methoxycyclohexane-1,2,3,4,5-pentol
(1r,2s,3s,4s,5r,6r)-6-methoxycyclohexane-1,2,3,4,5-pentaol
Q7269871
HY-N2375
CS-0022555
MS-23047
DTXSID80957028
A867922
SCHEMBL22975188
DTXSID601029528
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
cyclohexanolsAn alcohol in which one or more hydroxy groups are attached to a cyclohexane skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID1159550Human Phosphogluconate dehydrogenase (6PGD) Inhibitor Screening2015Nature cell biology, Nov, Volume: 17, Issue:11
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID334031Inhibition of Naja Naja PLA2 at 1.3 nM1997Journal of natural products, Nov, Volume: 60, Issue:11
Zanhasaponins A and B, antiphospholipase A2 saponins from an antiinflammatory extract of Zanha africana root bark.
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (14.29)18.7374
1990's1 (4.76)18.2507
2000's7 (33.33)29.6817
2010's7 (33.33)24.3611
2020's3 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 31.53

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index31.53 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index34.57 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (31.53)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.55%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other21 (95.45%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]